Amita Kalra, MD
Internal Medicine · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kalra’s office at (650) 736-5555 to ask if they take your plan before you enroll.
California Medical Board record
Licence A127732 · Current
Licensed to practise in California · since 2013 · expires 2027-11-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Drugs they prescribed that Part D paid
$8,179
Pharmacies billed $8,179 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 37) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
30 generic and fewer than 11 brand-name prescriptions · $8,179 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 37 | None | 0% (0) | None | $8,179 |
| 2023 | 38 | None | None | 50% | $22,859 |
| 2020 | 55 | 28 | 0% (0) | None | $7,885 |
| 2019 | 167 | 84 | 0% (0) | 17% | $21,304 |
| 2018 | 109 | 55 | 0% (0) | 20% | $6,067 |
| 2017 | 73 | 30 | 0% (0) | 26% | $6,242 |
| 2016 | 30 | 13 | 0% (0) | 43% | $103,988 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Mounjaro | 15 | $18,690 | $1,246 |
2020: 1 drug
| Pantoprazole | 16 | $368 | $23 |
2019: 5 drugs
| Pantoprazole | 24 | $389 | $16 |
| Peg 3350-Electrolyte | 19 | $338 | $18 |
| Omeprazole | 30 | $288 | $10 |
| Gavilyte-N | 16 | $242 | $15 |
| Gavilyte-G | 14 | $204 | $15 |
2018: 4 drugs
| Polyethylene Glycol 3350 | 24 | $2,324 | $97 |
| Peg 3350-Electrolyte | 15 | $273 | $18 |
| Omeprazole | 15 | $141 | $9 |
| Pantoprazole | 13 | $119 | $9 |
2017: 2 drugs
| Apriso | 11 | $4,955 | $450 |
| Polyethylene Glycol 3350 | 17 | $424 | $25 |
Money from drug and device companies
$39 in 2025
| 2025 | 2 | 2 | None | $39 |
| 2024 | 3 | 3 | None | $58 |
| 2023 | 1 | 2 | None | $59 |
| 2022 | 2 | 6 | None | $143 |
| 2021 | 7 | 10 | None | $199 |
| 2019 | 2 | 2 | None | $234 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ardelyx | Ibsrela | $24 | 1 payment
|
| Novo Nordisk | Wegovy | $16 | 1 payment
|
See all 2 published payments
| Ardelyx | Meals · 2025-04-30 | Ibsrela | $24 |
| Novo Nordisk | Meals · 2025-04-24 | Wegovy | $16 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $58
| Novo Nordisk | Wegovy | $23 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $21 | 1 payment
|
| Endogastric Solutions | Esophyx | $14 | 1 payment
|
2023: $59
| Abbvie | Viberzi | $59 | 2 payments
|
2022: $143
| Abbvie | Creon | $130 | 5 payments
|
| Novo Nordisk | Saxenda | $13 | 1 payment
|
2021: $199
| AbbVie | Creon | $46 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $43 | 2 payments
|
| RedHill Biopharma | Aemcolo | $41 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $23 | 1 payment
|
| QOL Medical | Sucraid | $18 | 1 payment
|
| Pfizer | Xeljanz | $17 | 1 payment
|
| Novo Nordisk | Wegovy | $12 | 1 payment
|
2019: $234
| Boston Scientific | Watchman | $127 | 1 payment
|
| Nevro | Senza Spinal Cord Stimulation System | $107 | 1 payment
|
Professional record
- NPI
- 1548551484
- Licence
- CA A127732, CT 54741California A127732: Current · expires 2027-11-30
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 900 Blake Wilbur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2011-04-26
- NPI last updated
- 2018-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Clarkson Ave, Brooklyn, NY, 11203